QA: Abcellera Biologics Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001703057_2026_Abcellera_Biologics_Inc.pdf

Logs

Graph

Absolute values for 0001703057, Abcellera Biologics Inc

  xvar xval
0 AssetsCurrent 728,232,000
1 IntangibleAssetsNetIncludingGoodwill 86,187,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 542,531,000
4 LiabilitiesCurrent 64,307,000
5 LiabilitiesNoncurrent 325,739,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 90,063,329
9 ResearchAndDevelopmentExpense 205,188,330
10 remainder_Expenses 8,222,119
11 remainder_Revenues 74,575,120
12 remainder_NetIncome 56,388,061
13 remainder_ComprehensiveNetIncome -2,655,723
  yvar yval
0 Assets 1,356,950,000
1 Liabilities 390,046,000
2 Expenses 303,473,778
3 Revenues 74,575,120
4 StockholdersEquity 966,904,000
5 NetIncome -172,510,597
6 ComprehensiveNetIncome -173,838,458
7 BaseVar 1,092,044,341
8 EconomicCapitalRatiobeforeLimitedLiability 2.21
9 EconomicCapitalRatio 3.17

Edgar->Model Mapping

Feature Distribution

Change over Time